candesartan cilexetil has been researched along with Airway Hyper-Responsiveness in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan cilexetil did not inhibit antigen-induced bronchoconstriction in sensitized guinea pigs or alter PC(200) in nonsensitized guinea pigs." | 1.31 | Type 1 angiotensin II receptor antagonism reduces antigen-induced airway reactions. ( Fujimura, M; Hirose, T; Kurashima, K; Myou, S; Tachibana, H; Watanabe, K, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Myou, S | 1 |
| Fujimura, M | 1 |
| Kurashima, K | 1 |
| Tachibana, H | 1 |
| Watanabe, K | 1 |
| Hirose, T | 1 |
1 other study available for candesartan cilexetil and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Type 1 angiotensin II receptor antagonism reduces antigen-induced airway reactions.
Topics: Angiotensin Receptor Antagonists; Animals; Antigens; Benzimidazoles; Biphenyl Compounds; Bronchocons | 2000 |